tepotinib 225 MG Oral Tablet
- RxCUI
- 2477266
- RxNorm name
- tepotinib 225 MG Oral Tablet
- Display name
- tepotinib 225 MG Oral Tablet
- Full name
- tepotinib 225 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TEPMETKO | TEPOTINIB HYDROCHLORIDE | EMD Serono, Inc. | 80a0f1b9-071a-47f5-9e67-32d638a669dc | 2025-04-17 | Warnings, Adverse reactions | 2477266 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 80a0f1b9-071a-47f5-9e67-32d638a669dc | tepotinib 225 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use TEPMETKO safely and effectively. See full prescribing information for TEPMETKO. TEPMETKO ® (tepotinib) tablets, for oral use Initial U.S. Approval: 2021 | 20250417 |
| 80a0f1b9-071a-47f5-9e67-32d638a669dc | tepotinib 225 MG Oral Tablet | SCD | 8 | These highlights do not include all the information needed to use TEPMETKO safely and effectively. See full prescribing information for TEPMETKO. TEPMETKO ® (tepotinib) tablets, for oral use Initial U.S. Approval: 2021 | 20250417 |
| 80a0f1b9-071a-47f5-9e67-32d638a669dc | tepotinib 225 MG (equivalent to tepotinib HCl hydrate 250 MG) Oral Tablet | SY | 8 | These highlights do not include all the information needed to use TEPMETKO safely and effectively. See full prescribing information for TEPMETKO. TEPMETKO ® (tepotinib) tablets, for oral use Initial U.S. Approval: 2021 | 20250417 |